Enanta Pharmaceuticals: From Failure To Formidable
Source: Life Science Leader
By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
IMAGINE YOU WERE APPROACHED BY A RECRUITER WITH THE FOLLOWING PITCH:
CEO wanted for life sciences company that recently experienced significant failure. Provisos? Company currently has no investable assets. You won’t be able to raise any additional money, as the investors on the board want to avoid dilution. Chances of going public reside somewhere between slim and none.
And oh, by the way, your first order of business will be to lay off two-thirds of the company.
VIEW THE MAGAZINE ARTICLE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Life Science Leader? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
This website uses cookies to ensure you get the best experience on our website. Learn more